Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Infliximab may cause hair loss in Crohn's disease patients.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Ivermectin and sulfur effectively treated the cat's scabies and sporotrichosis in 14 days.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Brentuximab vedotin chemotherapy can cause long-term hair loss and emotional distress.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

CMV infection increases the risk of GvHD after bone marrow transplants.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

SeV-Tp speeds up healing of drug-resistant infections by targeting wounds and killing bacteria with light activation.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.